Literature DB >> 27512447

Pregnancy in women after coronary revascularization.

Joanne N Quiñones1, David Cox2, William J Smolinski2, Crystal A Maksimik2, Kara M Coassolo3, Ronald Freudenberger2.   

Abstract

Pregnancy after coronary revascularization presents unique challenges to the management of antiplatelet therapy, anesthesia and mode of delivery. We present two cases where women of reproductive age required coronary revascularization with drug eluting stents after a myocardial infarction, and discuss key aspects of pregnancy and labor management.

Entities:  

Keywords:  Cardiology; drugs (medication); high-risk pregnancy; maternal–fetal medicine

Year:  2014        PMID： 27512447      PMCID： PMC4934986          DOI： 10.1177/1753495X14546434

Source DB:  PubMed          Journal:  Obstet Med        ISSN： 1753-495X


  18 in total

1.  More similarities than differences: an international comparison of CVD mortality and risk factors in women.

Authors:  Leila Gholizadeh; Patricia Davidson
Journal:  Health Care Women Int       Date:  2008-01

2.  Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Authors:  Fausto Feres; Ricardo A Costa; Alexandre Abizaid; Martin B Leon; J Antônio Marin-Neto; Roberto V Botelho; Spencer B King; Manuela Negoita; Minglei Liu; J Eduardo T de Paula; José A Mangione; George X Meireles; Hélio J Castello; Eduardo L Nicolela; Marco A Perin; Fernando S Devito; André Labrunie; Décio Salvadori; Marcos Gusmão; Rodolfo Staico; J Ribamar Costa; Juliana P de Castro; Andrea S Abizaid; Deepak L Bhatt
Journal:  JAMA       Date:  2013-12-18       Impact factor: 56.272

Review 3.  Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.

Authors:  David E Kandzari; Dominick J Angiolillo; Matthew J Price; Paul S Teirstein
Journal:  JACC Cardiovasc Interv       Date:  2009-12       Impact factor: 11.195

4.  Effect of atenolol on birth weight.

Authors:  G Y Lip; M Beevers; D Churchill; L M Shaffer; D G Beevers
Journal:  Am J Cardiol       Date:  1997-05-15       Impact factor: 2.778

5.  Central hemodynamic assessment of normal term pregnancy.

Authors:  S L Clark; D B Cotton; W Lee; C Bishop; T Hill; J Southwick; J Pivarnik; T Spillman; G R DeVore; J Phelan
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

6.  Births: preliminary data for 2011.

Authors:  Brady E Hamilton; Joyce A Martin; Stephanie J Ventura
Journal:  Natl Vital Stat Rep       Date:  2012-10-03

7.  Clopidogrel use throughout pregnancy in a patient with a drug-eluting coronary stent.

Authors:  G Robert Myers; Matthew K Hoffman; Erik S Marshall
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.661

Review 8.  Cardiac output in normal pregnancy: a critical review.

Authors:  A C van Oppen; R H Stigter; H W Bruinse
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

9.  Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice.

Authors:  Antonio Tello-Montoliu; Naveen A Seecheran; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

10.  Case report: successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidrogel.

Authors:  P Klinzing; U R Markert; K Liesaus; G Peiker
Journal:  Clin Exp Obstet Gynecol       Date:  2001       Impact factor: 0.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.